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Edited by Maurice MontalAbstract In Shaker Kþ channels, formation of an electrostatic
interaction between two charged residues, D316 and K374 in
transmembrane segments S3 and S4, respectively, is a key step in
voltage sensor biogenesis. Mutations D316K and K374E disrupt
formation of the voltage sensor and lead to endoplasmic
reticulum retention. We have now investigated the fates of these
misfolded proteins. Both are signiﬁcantly less stable than the
wild-type protein. D316K is degraded by cytoplasmic protea-
somes, whereas K374E is degraded by a lactacystin-insensitive,
non-proteasomal pathway. Our results suggest that the D316K
and K374E proteins are misfolded in recognizably diﬀerent ways,
an observation with implications for voltage sensor biogenesis.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Biogenesis1. Introduction
Voltage-dependent Kþ channels control the excitability of
nerve and muscle. Normally closed at the hyperpolarized
membrane potentials characteristic of resting cells, they open
upon depolarization, resulting in a Kþ current across the
plasma membrane [1]. Kþ channels contain four subunits that
surround the pore for ion conduction [2–4]. Each subunit has
six transmembrane segments, S1–S6, and a reentrant P loop.
Segments S1–S4 contain the voltage sensor [5,6]. Charged
residues in this domain, located primarily in S4, interact elec-
trostatically with the membrane potential [7,8]. In response to
depolarization, these residues initiate conformational changes
that increase the probability of pore opening. S5, S6, and the* Corresponding author. Fax: +1-310-206-5661.
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doi:10.1016/j.febslet.2004.05.023intervening P loop form the central pore domain [9]. The P
loop lines the narrowest region of the pore, conferring selec-
tivity for Kþ over other cations.
Although much has been learned in recent years about the
structure and function of the voltage sensor and pore in Kþ
channels [5,6,9–11], little is known about how these domains
form during channel biogenesis [12]. We have investigated
formation of the voltage sensor in Shaker Kþ channels using a
second site suppressor strategy [6,13,14]. The results indicate
that two conserved charged residues, D316 in S3 and K374 in
S4, form a short-range electrostatic interaction that is essential
for generation of the voltage sensor [6,14]. Interestingly, ion
pairs between residues in diﬀerent transmembrane segments
are seen in the high resolution X-ray structure of the voltage
sensor from KvAP, a prokaryotic voltage-dependent Kþ
channel [15]. In Shaker, charge reversal mutations D316K and
K374E disrupt folding of the protein, trapping it in the en-
doplasmic reticulum (ER) in an immature, core glycosylated
form [14]. Combination of the two mutations in a single sub-
unit, however, restores maturation and the ability of the sub-
units to incorporate into functional channels [14]. Consistent
with these results, the D316K and K374E single mutant pro-
teins lack a hallmark of the native structure, the ability to form
an intersubunit disulﬁde bond between two cytoplasmic cys-
teine residues (C96 and C505) upon exposure of intact cells to
mild oxidizing conditions [3,16]. In the double mutant,
D316K+K374E, the ability to form this disulﬁde bond is re-
covered, consistent with restoration of the native structure [16].
Previous studies indicate that many ER-retained proteins are
dislocated from the ER and degraded by cytoplasmic protea-
somes [17–25]. Whether this pathway is used to dispose of
misfolded channel subunits has been little explored [26]. In this
study, we investigated the fates of the misfolded D316K and
K374E single mutant proteins in mammalian cells. We ﬁnd
that D316K and K374E are signiﬁcantly less stable than the
wild-type Shaker protein. Degradation of D316K is inhibited
by lactacystin, implicating cytoplasmic proteasomes in the
turnover of this mutant. In contrast, K374E is degraded by a
lactacystin-insensitive pathway. Our data suggest that both
proteasomal and non-proteasomal pathways dispose of mis-
folded channel subunits.2. Materials and methods
2.1. Cell culture, transfection, antibodies, and reagents
Human embryonic kidney cells (HEK293T) were cultured as de-
scribed [27] and transfected in 35-mm wells with 1 lg of plasmid DNAation of European Biochemical Societies.
Fig. 1. Degradation of D316K and K374E mutant proteins is diﬀer-
entially sensitive to lactacystin. (A,C) D316K and K374E were ex-
pressed in HEK293T cells, metabolically labeled, and chased for the
indicated times in the absence or presence of the proteasomal inhibitor,
lactacystin (Lac, 10 lM). Following solubilization, Shaker proteins
were immunoprecipitated and subjected to electrophoresis and ﬂuo-
rography. Representative ﬂuorographs for D316K (A) and K374E (C)
are shown. The arrow indicates the position of the immature, core-
glycosylated mutant protein. In addition to the immature band, a
sharp band with an apparent molecular weight of 100 kDa is visible in
(A) immediately after the pulse and then disappears rapidly thereafter
(position denoted by s). The same unstable band is seen immediately
after the pulse upon expression of the wild-type protein; the band is
degraded in the interval before substantial maturation of the wild-type
protein occurs (see Fig. 3 in [27]). The identity of this band has not
been determined. It does not correspond to the mature form of Shaker,
which migrates as a broad band exhibiting high stability [27,30]. It was
M.P. Myers et al. / FEBS Letters 568 (2004) 110–116 111encoding wild-type, D316K, D316F, D316R, K374E, or
D316K+K374E Shaker using Cytofectene (BioRad, Hercules, CA).
Antibodies directed against a Shaker-b-galactosidase fusion protein
were the generous gift of Dr. L.Y. Jan (UCSF) [28]. An antibody
against the ER marker calnexin was purchased from Aﬃnity Biore-
agents Inc. (Golden, CO). Alexa-conjugated goat anti-rabbit and goat
anti-mouse secondary antibodies were obtained fromMolecular Probes
(Eugene, OR). Clasto-lactacystin-b-lactone (Lac), which is the active
intermediate in lactacystin-mediated covalent inactivation of the 20S
catalytic core of the proteasome, was from Calbiochem (La Jolla, CA)
[29]. Deoxynojirimycin (dNJ) and deoxymannojirimycin (dMJ) were
purchased from Toronto Research Chemicals (Toronto, Ont., Canada).
2.2. Metabolic labeling, immunoprecipitation, electrophoresis, and
ﬂuorography
Metabolic labeling, immunoprecipitation, electrophoresis, and
ﬂuorography were performed as described previously [27]. Forty-eight
hours post-transfection, cells were incubated for 30 min in methionine-
and cysteine-free Dulbecco’s modiﬁed Eagle’s medium (Mediatech,
Herndon, VA), pulsed with 0.2–0.5 mCi/ml [35S]methionine and
[35S]cysteine (Tran35S-Label, ICN, Irvine, CA) for 30 min, and chased
for various times in complete, non-radioactive medium. Cells subjected
to lactacystin (10 lM) treatment were pre-incubated for 12–16 h with
the drug, which was also present throughout the pulse and chase pe-
riods. Cells were incubated with other drugs for 2–6 h prior to the start
of metabolic labeling and during the pulse and chase periods.
For electrophoresis, each sample loaded was derived from an aliquot
of cell lysate containing an equal number of tricholoroacetic acid-
precipitable counts per minute. Protein bands were quantiﬁed by
densitometry (Personal Densitometer SI, Molecular Dynamics,
Amersham Biosciences, Sunnyvale, CA) using Molecular Dynamics
ImageQuant software (v.4.2, Molecular Dynamics).
2.3. Oxidation of C96/C505 intersubunit disulﬁde bonds
Intact cells expressing wild-type or mutant Shaker proteins were
washed with divalent-free phosphate-buﬀered saline (PBS) prior to
oxidation with 100 mM H2O2 for 15 min. The reaction was quenched
by addition of 5 mM N -ethylmaleimide for 5 min [3]. Shaker protein
was then solubilized, immunoprecipitated, and boiled for 5 min in
Laemmli sample buﬀer containing 16 mM iodoacetamide (non-
reducing conditions) [27].
2.4. Immunoﬂuorescence microscopy
Indirect immunoﬂuorescence microscopy was performed on ﬁxed,
permeabilized cells as described previously [30]. Cells were incubated
for 2 h at room temperature with a polyclonal rabbit antiserum di-
rected against a Shaker b-galactosidase fusion protein (1:200 dilution
in 3% bovine serum albumin in PBS) and a mouse monoclonal anti-
body against calnexin (1:250 dilution). Cells were then washed with
PBS and incubated with ﬂuorescent-conjugated secondary antibodies
(Alexa-488-conjugated goat anti-rabbit [1:1000] and Alexa-568-conju-
gated goat anti-mouse [1:1500]) for 1 h at room temperature. Images
were acquired on an inverted laser scanning confocal microscope with
a 63 quartz objective (Leica Dm IRB/E, Meyer Instruments Inc.,
Houston, TX).not included in any of the calculations described in this paper. (B,D)
Summary of densitometric analysis of the turnover of the immature
Shaker protein for (B) D316K (open circles, n ¼ 8) and D316K+Lac
(ﬁlled circles, n ¼ 5), and (D) K374E (open squares, n ¼ 4–6) and
K374E+Lac (ﬁlled squares, n ¼ 3). The amount of protein in the
immature band was quantiﬁed by densitometry, normalized to the
amount of Shaker protein at time 0, and plotted versus chase time.
Unless otherwise stated, the data in this and subsequent ﬁgures are
provided as meansS.E.M. For the D316K mutant, the half time of
degradation (t1=2) was estimated to be 2 h in the absence and 4.4 h in
the presence of Lac. The t1=2 for the K374E mutant was estimated to be
15 h in the absence and 17 h in the presence of Lac. For comparison, at
24 h 98% of the wild-type Shaker protein remained either in the
absence (open diamonds, n ¼ 14) or presence (ﬁlled diamonds, n ¼ 4)
of Lac [30].3. Results
3.1. Diﬀerent pathways dispose of the D316K and K374E
proteins
To test the hypothesis that the ER-retained mutant proteins
D316K and K374E are less stable than the wild-type Shaker
protein, we characterized their turnover times by pulse chase
analysis. HEK293T cells expressing D316K or K374E were
metabolically labeled during a 30-min pulse, and were either
harvested immediately or incubated in non-radioactive me-
dium for chase periods up to 24 h (Fig. 1). After detergent
extraction, the Shaker protein was immunoprecipitated and
subjected to electrophoresis and ﬂuorography. As previously
reported, the D316K and K374E proteins were detected as the
core-glycosylated, immature form characteristic of the ER,and did not acquire complex glycosylation [14,16,31]. The
D316K protein was rapidly degraded: 15 3% of the D316K
protein remained after 6 h (Fig. 1A and B). The K374E mutant
Fig. 2. Diﬀerent D316 mutations target the Shaker protein to pro-
teasomes for degradation. (A,B) D316F and D316R mutant Shaker
proteins were metabolically labeled and treated as described under Fig.
1. Representative ﬂuorographs are shown for D316F (A) and D316R
(B). The arrow indicates the position of the immature, core-glycosy-
lated mutant protein. An unstable band of unknown identity with an
apparent molecular weight of 100 kDa is also visible (denoted by s,
see Fig. 1 legend). (C) Summary of densitometric analysis of turnover
for D316F (open squares, n ¼ 3), D316F+Lac (ﬁlled squares, n ¼ 3),
D316R (open triangles, n ¼ 3; except n ¼ 1 for the 9 h and n ¼ 2 for
the 24 h time points) and D316R+Lac (ﬁlled triangles, n ¼ 3; except
n ¼ 1 for the 9 h and n ¼ 2 for the 24 h time points). The amount of
protein in the bands was quantiﬁed by densitometry, normalized to the
amount of immature Shaker protein at time 0, and plotted versus chase
time. The t1=2 for the D316F mutant was estimated to be 1 h in the
absence and 5 h in the presence of Lac. The t1=2 for the D316R mutant
was estimated to be 1.5 h in the absence and 3 h in the presence of Lac.
The diamond symbols have the same meaning as in Fig. 1B and D.
Data are provided as mean S.E.M. except for the 9 and 24 h time
points. (D) Representative diﬀerential image contrast and confocal
images of HEK293T cells transiently transfected with D316F, D316R,
or wild-type Shaker. Forty eight hours post-transfection, cells were
permeabilized and labeled with a rabbit polyclonal antiserum directed
against a Shaker-b-galactosidase fusion protein and a mouse mono-
clonal antibody directed against calnexin (an ER-resident protein) and
visualized by incubation with ﬂuorescent-conjugated Alexa-488 goat
anti-rabbit (Shaker, green) and Alexa-568 goat anti-mouse (calnexin,
red) secondary antibodies, respectively. For each panel, the same
confocal plane was used for acquisition. Yellow regions in the merged
images represent co-localization of mutant Shaker proteins and caln-
exin. Calibration bar, 10 lm.
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mained after 6 h (Fig. 1C and D). However, both were sig-
niﬁcantly less stable than the wild-type protein, which shows
little degradation in HEK293T cells over 24 h [30].
To determine whether cytoplasmic proteasomes contribute
to the degradation of the D316K and K374E proteins, turn-
over rates were compared in the presence and absence of
lactacystin, a proteasome-speciﬁc inhibitor [29]. Treatment
with lactacystin signiﬁcantly slowed degradation of the D316K
protein: at 6 h, 46 8% of the mutant protein remained
(Fig. 1A and B). In contrast, lactacystin had no signiﬁcant
eﬀect on the turnover of the K374E protein (Fig. 1C and D).
These results indicate that the D316K and K374E proteins
have diﬀerent fates. D316K is degraded, at least in part, by
cytoplasmic proteasomes, whereas disposal of K374E occurs
via a lactacystin-insensitive pathway.
3.2. Multiple D316 mutants are degraded by proteasomes
To investigate whether the nature of the mutation at D316
was important for targeting the Shaker protein to cytoplasmic
proteasomes for degradation, we generated the D316R and
D316F mutations. Pulse chase analysis revealed that the
D316F and D316R mutant proteins did not mature and were
rapidly degraded: at 6 h, 10% of the D316F (Fig. 2A and C)
and 5% of the D316R proteins remained (Fig. 2B and C).
Similar to the D316K mutant, the degradation of both D316F
and D316R was signiﬁcantly inhibited by lactacystin: at 6 h,
45% of both proteins remained (Fig. 2A–C). These results
indicate that several mutations of residue 316 destabilize the
Shaker protein and target it for degradation by cytoplasmic
proteasomes. Consistent with the lack of maturation and in-
stability of D316F and D316R, immunoﬂuorescence micros-
copy indicated that these proteins were retained intracellularly
where they partially co-localized with the ER marker, calnexin
(Fig. 2D). In contrast, the wild-type Shaker protein was de-
tected primarily at the cell surface with little or no overlap with
calnexin (Fig. 2D).
3.3. Diﬀerential stability of mature and immature forms of the
D316K+K374E double mutant
We have previously shown that combining the D316K and
K374E mutations in the same subunit restores maturation to a
complex glycosylated form [14]. Upon expression in Xenopus
oocytes, approximately 85% of the D316K+K374E double
mutant protein matures [14]. Two lines of evidence indicate
that this mature protein is properly folded. First, the double
mutant subunit incorporates eﬃciently into functional chan-
nels in which the voltage dependence of activation is shifted in
the depolarized direction [14]. Second, the D316K+K374E
double mutant protein has the ability to form an intersubunit
disulﬁde bond between two cytoplasmic cysteine residues, C96
and C505 upon exposure of intact cells to mild oxidizing
conditions [16]. This disulﬁde bond can be eﬃciently oxidized
in the wild-type Shaker protein, whether it is located at the cell
surface or in the ER, and in mutant proteins that fold and
assemble properly as evidenced by maturation and functional
activity [16,32]. However, the C96/C505 disulﬁde bond cannot
be detected in a variety of ER-retained mutant proteins [16].
Thus, the C96/C505 disulﬁde bond serves as a hallmark for the
native Shaker structure, providing an indirect measure of the
ability of a mutant protein to fold and assemble properly
[3,16,30,32,33].In HEK293T cells, maturation of the D316K+K374E
protein was somewhat reduced compared to oocytes, but still
substantial, with about 50% of the protein being converted to
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ability of the wild-type, D316K, K374E, and D316K+K374E
proteins to form the C96/C505 disulﬁde bond in mammalian
cells, intact cells expressing these proteins were metabolically
labeled and incubated with 100 mM H2O2. Remaining free
sulfhydryl groups were protected with N -ethylmaleimide prior
to solubilization and immunoprecipitation. Electrophoresis
under non-reducing conditions revealed that the Shaker wild-
type protein and the D316K+K374E double mutant were
converted to higher molecular weight adducts corresponding
to dimer, trimer, linear tetramer, and circular tetramer
(Fig. 3B) [3,30]. In contrast, disulﬁde-bonded adducts could
not be detected in the D316K or K374E single mutant proteins
(Fig. 3B). These results are consistent with the idea that the
D316K and K374E proteins fail to fold properly, whereas
some of the D316K+K374E protein adopts the native struc-
ture in mammalian cells [14,16].
We investigated the stability of the mature and immature
forms of the double mutant protein, D316K+K374E, by pulseFig. 3. D316K+K374E protein forms C96/C505 disulﬁde bond in
mammalian cells. (A) The wild-type, D316K, K374E, and
D316K+K374E proteins were expressed in HEK293T cells, meta-
bolically labeled for 30 min and chased for 3 h in non-radioactive
medium. Shaker protein was immunoprecipitated, and electrophoresis
was performed under reducing conditions. A representative ﬂuoro-
graph is shown (n ¼ 3). The arrowhead indicates the position of the
mature, complex glycosylated protein. The arrow indicates the position
of the immature, core-glycosylated protein. (B) Intact cells were met-
abolically labeled for 30 min, chased in non-radioactive medium for 3
h, and oxidized with 100 mM hydrogen peroxide for 15 min. Re-
maining free sulfhydryl groups were protected with N -ethylmaleimide.
Shaker protein was immunoprecipitated, and electrophoresis was
performed under non-reducing conditions on 5–20% gradient (left
panel) or 7.5% (right panel) SDS–PAGE gels. Arrowheads indicate the
positions of the bands corresponding to monomer, dimer, trimer, lin-
ear tetramer, and circular tetramer. Diagrams show schematically the
predicted structures of each band [3].chase analysis. The mature form of the D316K+K374E pro-
tein was extremely stable with little or no degradation for up to
36 h (Fig. 4A). Lactacystin had no eﬀect on the mature
D316K+K374E protein (Fig. 4A). Thus, the stability of the
mature form of D316K+K374E is comparable to that of the
wild-type protein, consistent with the conclusion that it folds
and assembles properly [14,16].
The behavior of the immature form of D316K+K374E
diﬀered from that of the wild-type protein. We have previously
shown that the immature form of the wild-type Shaker protein
matures in HEK293T cells with a half time of approximately
45 min [31]. Maturation is virtually complete in 2 h [27]. In
contrast, as noted above, the maturation of D316K+K374E is
incomplete in mammalian cells. A fraction of the immature
form of D316K+K374E failed to mature, persisting in cellsFig. 4. The mature and immature forms of the D316K+K374E pro-
tein are diﬀerentially stable. The D316K+K374E double mutant was
metabolically labeled and treated as described under Fig. 1. (A)
Summary of densitometric analysis of protein turnover for the
mature band of D316K+K374E (open circles, n ¼ 3) and
D316K+K374E+Lac (ﬁlled circles, n ¼ 3). The amount of protein in
the mature band was quantiﬁed by densitometry, normalized to the
amount of mature Shaker protein present at time 3 h, and plotted
versus chase time. (B) Summary of densitometric analysis of protein
turnover for the immature band of D316K+K374E (open squares,
n ¼ 3) and D316K+K374E+Lac (ﬁlled squares, n ¼ 3). The amount
of protein in the immature band was quantiﬁed by densitometry,
normalized to the amount of immature Shaker protein present at time
3 h, and plotted versus chase time. Note that at time 0, the total
D316K+K374E protein is in the form of an immature band that
represents a mixed population. About 50% of this protein will mature,
a process that should be complete by approximately 2 h of chase [27].
After 3 h of chase, maturation is expected to be complete, so further
change in the amounts of the mature and immature bands primarily
reﬂects turnover. Therefore, the turnover of the mature and immature
bands was assessed relative to the 3 h time point. The half time of
degradation (t1=2) for the immature form of D316K+K374E was es-
timated to be 4.5 h in the absence of Lac, a value that is intermediate
between estimated t1=2 values for the D316K and K374E single mu-
tants, which were 2 and 15 h, respectively (see Fig. 1 legend).
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was subsequently degraded with rapid kinetics intermediate to
those of the single D316K and K374E mutants (Fig. 4B).
Degradation of the immature D316K+K374E protein was
inhibited by lactacystin, implicating proteasomes in its dis-
posal (Fig. 4B). Thus, the immature and mature forms of the
double mutant protein are diﬀerentially stable. The results
suggest that the immature form that persists past 2 h of chase
represents a fraction of D316K+K374E protein that fails to
fold properly in mammalian cells.
3.4. Role of glycan processing in the diﬀerential turnover of
D316K and K374E
Several recent reports indicate that interaction with the
lectin chaperone calnexin and trimming of the core glycan play
key roles in targeting glycoproteins for ER-associated degra-
dation (ERAD) [17–25,34]. For some proteins, interaction
with calnexin has been shown to inhibit ERAD, whereas
processing of the core glycan by ER mannosidase I promotes
degradation [19–21,35]. We have previously shown that caln-Fig. 5. Processing of core glycan is not required for turnover of D316K
or K374E. (A) Cells expressing D316K were metabolically labeled for
30 min and either harvested immediately or chased for 6 h. Cells were
either untreated (control) or treated with Lac alone (control +Lac), or
treated with dNJ or dMJ in the absence or presence of Lac. The per-
cent protein remaining at 6 h of chase is shown for each condition,
n ¼ 2. Values shown represent meansS.D. (B) Cells expressing
K374E were labeled for 30 min and either harvested immediately or
chased for 24 h. Cells were treated as described in (A). The percent
protein remaining at 24 h of chase is shown for each condition, n ¼ 2,
except for ‘‘control +Lac’’, n ¼ 1. Values shown represent
meansS.D., except for ‘‘control+Lac’’.exin interacts transiently with the Shaker protein soon after its
synthesis [31]. Interestingly, the time course of association with
calnexin is similar for the Shaker wild-type, D316K, and
K374E proteins, indicating that the misfolded mutant proteins
escape the folding sensor of the calnexin chaperone system
[31]. We have also presented evidence that transient interaction
with calnexin confers long-term protection from ERAD on
properly folded Shaker protein that is localized in the ER [36].
We therefore investigated the role of calnexin interaction and
glycan trimming in the quality control pathways that dispose
of D316K and K374E.
To prevent interaction with calnexin, cells expressing D316K
or K374E were incubated co- and post-translationally with
dNJ, which inhibits ER glucosidases I and II and thereby
prevents formation of the monoglucosylated core glycan that
is recognized by calnexin. We have previously shown that
treatment with dNJ abolishes association of the Shaker protein
with calnexin [36]. In parallel experiments, cells were incubated
with dMJ, a general inhibitor of mannosidase activity. Neither
drug altered the turnover of the D316K and K374E proteins
(Fig. 5). We conclude that processing of the core glycan is not
required for degradation of D316K or K374E.4. Discussion
4.1. Evidence for proteasomal and non-proteasomal disposal
pathways involved in quality control of misfolded channel
mutants
In Shaker channels, mutations D316K in S3 and K374E in
S4 disrupt an electrostatic structural interaction that is essen-
tial for biogenesis of the voltage sensor [14,16]. In this study,
we have investigated pathways used by mammalian cells to
dispose of the misfolded D316K and K374E proteins. We ﬁnd
that these mutations diﬀerentially target the Shaker protein to
lactacystin-sensitive and -insensitive disposal pathways.
D316K is degraded, at least in part, by the lactacystin-sensitive
proteasome pathway. In contrast, disposal of K374E is unaf-
fected by lactacystin, suggesting that a non-proteasomal
pathway degrades the K374E protein.
Although a number of studies have suggested that non-
proteasomal pathways are involved in ERAD, the molecular
components involved have not been identiﬁed [37,38]. As a
result, it has been suggested that proteasomes are the main
pathway responsible for ERAD [39]. Although we have been
unable to identify the pathway responsible for disposal of the
K374E protein (see below), our results appear to be incom-
patible with the idea that proteasomes are solely responsible
for ERAD of misfolded Shaker proteins. The D316K and
K374E proteins diﬀer from each other by only one amino acid
residue, yet their degradation is diﬀerentially sensitive to lact-
acystin. Although proteasomes contain multiple proteolytic
activities [40–42], the overall sequence identity of the D316K
and K374E proteins suggests that the same protease compo-
nents would degrade both of them, and that these proteases
would therefore be equally sensitive to inhibition by lactacy-
stin. For these reasons, we conclude that both proteasomal
and non-proteasomal pathways are likely to participate in the
disposal of misfolded, ER-retained Shaker proteins in mam-
malian cells.
Despite earnest attempts to characterize the lactacystin-
insensitive pathway, its identity remains elusive. Degradation
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lysosomal proteases or a cytoplasmic ‘‘giant’’ protease that
under some circumstances substitutes for the proteasome (data
not shown) [43,44]. Furthermore, no evidence was found that
D316K and K374E form aggresomes, an alternative disposal
pathway in which misfolded protein forms an inclusion body
located at the microtubule organizing center (data not shown)
[45]. One study reported a phenylarsine oxide-sensitive path-
way in ERAD, implicating a tyrosine phosphatase activity in a
non-proteasomal ER disposal pathway [37]. We have been
unable to evaluate this pathway in our work due to the extreme
toxicity of the drug during long pulse chase experiments (data
not shown) [25]. Further work will be required to characterize
the proposed non-proteasomal ERAD pathway.
4.2. Possible implications for voltage sensor biogenesis
Our results indicate that the cellular quality control ma-
chinery is able to distinguish between D316K and K374E,
suggesting that these proteins are misfolded in recognizably
diﬀerent ways. If so, our results have implications for the
mechanism of voltage sensor biogenesis. Data from in vitro
models suggests that the folding of polytopic membrane pro-
teins involves at least two stages [46,47]. In the ﬁrst stage, the
protein establishes its secondary structure and membrane to-
pology. In the second stage, tertiary interhelical interactions
are formed, leading to the condensed, properly folded struc-
ture. Our previous results suggest that the D316K and K374E
mutations aﬀect the formation of a tertiary interaction be-
tween transmembrane segments S3 and S4 [14]. One possibility
suggested by the two-stage model is that the two mutant
proteins might be able to establish the correct membrane to-
pology but fail to form the proper condensed structure.
However, this predicts that the mutant proteins would be
misfolded in similar ways, which appears to be inconsistent
with our ﬁndings. An alternative possibility is that the mutant
proteins diﬀer in their ability to establish the proper membrane
topology. For instance, insertion of S3 and S4 into the mem-
brane may not be independent events during biogenesis of the
voltage sensor. Interestingly, Deutsch and colleagues [48] have
presented evidence that S3 and S4 interact during biogenesis,
whereas Sato et al. [49] report that membrane insertion of an
S4 segment derived from a plant Kþ channel depends on the
presence of S3. If so, it may be necessary to form an interaction
between positions 316 and 374 before the S4 segment can be
inserted into the membrane.
Although the diﬀerences between the misfolded structures
adopted by D316K and K374E are unknown, at least one
possibility can be suggested. In the presence of the D316K
mutation, the S4 segment may fail to insert into the membrane,
leading to an aberrant topology. In the presence of the K374E
mutation, D316 in S3 may mispair with one of the other
positively charged residues in S4, leading to insertion of both
the S3 and S4 segments but with an incorrect set of tertiary
contacts. In this case the proper condensed structure
would not be formed despite the presence of the appropriate
topology.
We found that several D316 mutations resulted in prote-
asomal degradation of the Shaker protein. Furthermore, the
persistent immature form of the D316K+K374E double mu-
tant was degraded by proteasomes with rapid kinetics. The
structural epitope(s) involved in targeting these proteins to
proteasomes for degradation have not been identiﬁed. Onepossibility is that D316K, D316R, D316F, and the immature
form of the D316K+K374E protein have a common mis-
folded structure, which diﬀers from that of the K374E single
mutant. In this regard, the double mutant protein is of par-
ticular interest. When the D316K and K374E mutations are
combined in a single subunit, much of the protein is able to
fold properly and mature [14,16]. A fraction, however, remains
misfolded.
In summary, our results provide evidence that voltage sen-
sor mutations diﬀerentially target the Shaker protein to pro-
teasomal and non-proteasomal disposal pathways. The results
suggest that D316K and K374E are misfolded in recognizably
diﬀerent ways. One possibility is that the mutations have dif-
ferential eﬀects on topogenesis, consistent with previous re-
ports suggesting that the insertion of an S4 segment is
dependent on S3 [48,49]. If so, this would suggest that the
interaction between D316 in S3 and K374 in S4 helps to
generate the correct membrane topology of the Shaker pro-
tein, as well as the condensed tertiary structure of the voltage
sensor.
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